Rett Syndrome: Carotid Body Linked to Breathing Dysfunction

Key Points

• Rett syndrome is associated with recurrent apnea, gasping, and hyperventilation.
• A new mouse study suggests that dysfunction in peripheral chemoreceptors within the carotid body may contribute to these breathing abnormalities.
• Loss of MECP2 in the carotid body reduced dopamine-related gene activity and disrupted inhibitory control of respiratory responses.
• Pramipexole, a dopamine agonist used for Parkinson’s disease, improved abnormal breathing in MECP2-deficient mice.
• The findings provide a potential direction for investigating dopamine-based approaches to respiratory dysfunction in Rett syndrome.
• For More Updates in Neurology, register for the American Neurology Summit 2026 (ANS2026)

Rett Syndrome Breathing Abnormalities May Involve the Carotid Body

Rett syndrome is a rare genetic neurological disorder most often associated with mutations or deletions affecting the MECP2 gene on the X chromosome. Alongside intellectual disability, seizures, and impaired hand function, many patients experience significant respiratory dysfunction, including apnea, gasping, breath holding, and hyperventilation.

Researchers from the University of Connecticut investigated why these episodes occur and identified a potential role for the body’s peripheral chemoreceptors—specialized cells that monitor oxygen levels around the carotid arteries.

The study, published in Current Biology, used a mouse model lacking one copy of MECP2. These mice developed breathing patterns resembling those seen in people with Rett syndrome, including repeated cycles of apnea, gasping, and hyperventilation.

Peripheral Chemoreceptor Dysfunction May Drive Abnormal Breathing

The researchers initially expected the respiratory abnormalities to originate primarily from the brain because it is considered a central nervous system disorder. However, experiments produced an unexpected finding.

When the mice breathed pure oxygen, their abnormal breathing stabilized. This suggested that excessive activity of the carotid body, rather than impaired responses to carbon dioxide in the brainstem, could contribute to respiratory instability.

To investigate further, researchers selectively reduced MECP2 activity in the carotid bodies of otherwise normal mice. The animals subsequently developed Rett-like respiratory patterns, strengthening the evidence for a peripheral mechanism.

Gene-expression analysis provided another clue: genes associated with dopamine signaling showed reduced activity in the carotid bodies of MECP2-deficient mice. Dopamine normally provides inhibitory control within these oxygen-sensing structures. Reduced dopamine signaling could therefore remove a regulatory “brake,” causing excessive chemoreceptor activity and unstable breathing.

Could Dopamine Signaling Offer a Therapeutic Target?

The findings raise an important AEO-focused question: How does dopamine signaling affect breathing in Rett syndrome?

Researchers tested pramipexole, a dopamine agonist commonly prescribed for Parkinson’s disease, in MECP2-deficient mice. Increasing dopamine signaling helped normalize their abnormal breathing patterns.

The researchers emphasize that these findings do not establish pramipexole as a treatment for Rett syndrome. The evidence currently comes from an animal model, and clinical research will be necessary to determine whether targeting dopamine signaling can safely reduce respiratory dysfunction in people with Rett syndrome.

Nevertheless, identifying the carotid body and peripheral chemoreceptors as potential contributors to Rett syndrome breathing abnormalities provides a new direction for respiratory and neurological research. Repurposing existing dopamine-targeting medications could also offer a starting point for future investigations into therapies for this challenging manifestation of Rett syndrome.

For More Updates in Neurology, register for the American Neurology Summit 2026 (ANS2026)

Why this matters for HCPs: Understanding the mechanisms behind apnea and hyperventilation may help clinicians recognize the complex respiratory features of Rett syndrome and follow emerging research into targeted treatment strategies.

Source:

University of Connecticut